|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN: Molecular pathology of malignant
gliomas. Annu Rev Pathol. 1:97–117. 2006. View Article : Google Scholar
|
|
3
|
Hulleman E and Helin K: Molecular
mechanisms in gliomagenesis. Adv Cancer Res. 94:1–27. 2005.
View Article : Google Scholar
|
|
4
|
Konopka G and Bonni A: Signaling pathways
regulating gliomagenesis. Curr Mol Med. 3:73–84. 2003. View Article : Google Scholar
|
|
5
|
Ohgaki H and Kleihues P: Population-based
studies on incidence, survival rates, and genetic alterations in
astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol.
64:479–489. 2005.
|
|
6
|
Claus EB and Black PM: Survival rates and
patterns of care for patients diagnosed with supratentorial
low-grade gliomas: data from the SEER program, 1973–2001. Cancer.
106:1358–1363. 2006.PubMed/NCBI
|
|
7
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cerchia L, Martinez Montero JC and
Monfared P: Signal transduction alterations in glioma: implications
for diagnosis and therapy. J Signal Transduct. 2012:7042472012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mellinghoff IK, Lassman AB and Wen PY:
Signal transduction inhibitors and antiangiogenic therapies for
malignant glioma. Glia. 59:1205–1212. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Kesari S, Rooney C, et al:
Inhibition of notch signaling blocks growth of glioblastoma cell
lines and tumor neurospheres. Genes Cancer. 1:822–835. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Strizzi L, Hardy KM, Seftor EA, et al:
Development and cancer: at the crossroads of Nodal and Notch
signaling. Cancer Res. 69:7131–7134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Purow BW, Haque RM, Noel MW, et al:
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1,
is critical for glioma cell survival and proliferation. Cancer Res.
65:2353–2363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pannuti A, Foreman K, Rizzo P, et al:
Targeting Notch to target cancer stem cells. Clin Cancer Res.
16:3141–3152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sriuranpong V, Borges MW, Ravi RK, et al:
Notch signaling induces cell cycle arrest in small cell lung cancer
cells. Cancer Res. 61:3200–3205. 2001.PubMed/NCBI
|
|
15
|
Ramdass B, Maliekal TT, Lakshmi S, et al:
Coexpression of Notch1 and NF-kappaB signaling pathway components
in human cervical cancer progression. Gynecol Oncol. 104:352–361.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sjölund J, Johansson M, Manna S, et al:
Suppression of renal cell carcinoma growth by inhibition of Notch
signaling in vitro and in vivo. J Clin Invest. 118:217–228.
2008.PubMed/NCBI
|
|
17
|
Fortini ME: Notch signaling: the core
pathway and its posttranslational regulation. Dev Cell. 16:633–647.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zardawi SJ, O’Toole SA, Sutherland RL and
Musgrove EA: Dysregulation of Hedgehog, Wnt and Notch signalling
pathways in breast cancer. Histol Histopathol. 24:385–398.
2009.PubMed/NCBI
|
|
19
|
Ristorcelli E and Lombardo D: Targeting
Notch signaling in pancreatic cancer. Expert Opin Ther Targets.
14:541–552. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Wang C, Meng Q, et al: siRNA
targeting Notch-1 decreases glioma stem cell proliferation and
tumor growth. Mol Biol Rep. 39:2497–2503. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dai J, Ma D, Zang S, et al: Cross-talk
between Notch and EGFR signaling in human breast cancer cells.
Cancer Invest. 27:533–540. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Noseda M, Chang L, McLean G, et al: Notch
activation induces endothelial cell cycle arrest and participates
in contact inhibition: role of p21Cip1 repression. Mol Cell Biol.
24:8813–8822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sarmento LM, Huang H, Limon A, et al:
Notch1 modulates timing of G1-S progression by inducing SKP2
transcription and p27 Kip1 degradation. J Exp Med. 202:157–168.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dakubo GD, Mazerolle CJ and Wallace VA:
Expression of Notch and Wnt pathway components and activation of
Notch signaling in medulloblastomas from heterozygous patched mice.
J Neurooncol. 79:221–227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao N, Guo Y, Zhang M, et al: Akt-mTOR
signaling is involved in Notch-1-mediated glioma cell survival and
proliferation. Oncol Rep. 23:1443–1447. 2010.PubMed/NCBI
|
|
26
|
Berry N, Gursel DB and Boockvar JA: Notch
inhibition via micro-RNA blocks glioma development. Neurosurgery.
70:N20–N22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Muto J, Imai T, Ogawa D, et al:
RNA-binding protein Musashi1 modulates glioma cell growth through
the post-transcriptional regulation of Notch and PI3 kinase/Akt
signaling pathways. PLoS One. 7:e334312012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Palomero T and Ferrando A: Therapeutic
targeting of NOTCH1 signaling in T-cell acute lymphoblastic
leukemia. Clin Lymphoma Myeloma. 9(Suppl 3): S205–S210. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mullendore ME, Koorstra JB, Li YM, et al:
Ligand-dependent Notch signaling is involved in tumor initiation
and tumor maintenance in pancreatic cancer. Clin Cancer Res.
15:2291–2301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sivasankaran B, Degen M, Ghaffari A, et
al: Tenascin-C is a novel RBPJkappa-induced target gene for Notch
signaling in gliomas. Cancer Res. 69:458–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan X, Mikolaenko I, Elhassan I, et al:
Notch1 and notch2 have opposite effects on embryonal brain tumor
growth. Cancer Res. 64:7787–7793. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen L, Zhang R, Li P, et al: P53-induced
microRNA-107 inhibits proliferation of glioma cells and
down-regulates the expression of CDK6 and Notch-2. Neurosci Lett.
534:327–332. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reichrath S, Müller CS, Gleissner B, et
al: Notch- and vitamin D signaling in 1,25(OH)2D3-resistant
glioblastoma multiforme (GBM) cell lines. J Steroid Biochem Mol
Biol. 121:420–424. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu P, Yu S, Jiang R, et al: Differential
expression of Notch family members in astrocytomas and
medulloblastomas. Pathol Oncol Res. 15:703–710. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu P, Zhang A, Jiang R, et al: The
different role of Notch1 and Notch2 in astrocytic gliomas. PLoS
One. 8:e536542013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu P, Qiu M, Zhang Z, et al: The oncogenic
roles of Notch1 in astrocytic gliomas in vitro and in vivo. J
Neurooncol. 97:41–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jin R, Nakada M, Teng L, et al:
Combination therapy using Notch and Akt inhibitors is effective for
suppressing invasion but not proliferation in glioma cells.
Neurosci Lett. 534:316–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rangarajan A, Hong SJ, Gifford A and
Weinberg RA: Species- and cell type-specific requirements for
cellular transformation. Cancer Cell. 6:171–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Noseda M and Karsan A: Notch and
minichromosome maintenance (MCM) proteins: integration of two
ancestral pathways in cell cycle control. Cell Cycle. 5:2704–2709.
2006. View Article : Google Scholar : PubMed/NCBI
|
